Predictive Oncology
POAI
POAI
17 hedge funds and large institutions have $157K invested in Predictive Oncology in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
48% less capital invested
Capital invested by funds: $300K → $157K (-$143K)
Holders
17
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$9.9K | |
| 2 | +$8.62K | |
| 3 | +$7.99K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.06K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$894 |
Top Sellers
| 1 | -$33K | |
| 2 | -$26.7K | |
| 3 | -$25.7K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$24.2K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$13.2K |